We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
DuPont de Nemours
DD
$18.6B
| $20.6M | 0.1% |
128,309
-4,320
| -3% | -$671K |
|
|
AKS
277
DELISTED
AK Steel Holding Corp
AKS
| $20.5M | 0.1% |
+2,855,890
| New | +$24.5M |
|
278
Electronic Arts
EA
$52.4B
| $20.2M | 0.1% |
226,047
+211,374
| +1,441% | +$18M |
|
279
Huntington Ingalls Industries
HII
$11.3B
| $20.2M | 0.1% |
100,981
-903
| -0.9% | -$184K |
|
280
Air Products & Chemicals
APD
$66.3B
| $19.8M | 0.09% |
146,027
-166,456
| -53% | -$23.5M |
|
281
ANI Pharmaceuticals
ANIP
$1.77B
| $19.7M | 0.09% |
398,691
+17,660
| +5% | +$992K |
|
282
RPM International
RPM
$13.7B
| $19.6M | 0.09% |
355,589
-5,075
| -1% | -$271K |
|
283
Merit Medical Systems
MMSI
$4.43B
| $19.4M | 0.09% |
+671,216
| New | +$18.8M |
|
284
Skywest
SKYW
$4.11B
| $19.3M | 0.09% |
566,146
+109,789
| +24% | +$3.92M |
|
285
Chesapeake Utilities
CPK
$3.26B
| $19.2M | 0.09% |
277,650
+9,338
| +3% | +$622K |
|
|
GIMO
286
DELISTED
Gigamon Inc.
GIMO
| $19.2M | 0.09% |
+540,848
| New | +$19.3M |
|
287
Eaton
ETN
$157B
| $19.1M | 0.09% |
257,854
+46,996
| +22% | +$3.34M |
|
288
Analog Devices
ADI
$181B
| $19.1M | 0.09% |
232,492
+26,347
| +13% | +$2.07M |
|
289
Bristol-Myers Squibb
BMY
$127B
| $18.9M | 0.09% |
346,964
-4,871
| -1% | -$267K |
|
|
UCB
290
United Community Banks
UCB
$4.22B
| $18.6M | 0.09% |
673,622
+646,417
| +2,376% | +$18.4M |
|
291
CVS Health
CVS
$137B
| $18.6M | 0.09% |
236,789
-11,202
| -5% | -$894K |
|
292
Ametek
AME
$55.5B
| $18.4M | 0.09% |
340,804
+14,304
| +4% | +$754K |
|
293
A.O. Smith
AOS
$8.38B
| $18.4M | 0.09% |
359,847
-373,809
| -51% | -$18.5M |
|
294
Tractor Supply
TSCO
$16.3B
| $18.3M | 0.09% |
1,326,305
+1,316,070
| +12,859% | +$19.2M |
|
|
LTXB
295
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $18.2M | 0.09% |
+456,412
| New | +$19M |
|
296
W.W. Grainger
GWW
$65.3B
| $18.1M | 0.09% |
77,717
-3,578
| -4% | -$881K |
|
297
Danaher
DHR
$135B
| $17.8M | 0.09% |
235,010
+7,104
| +3% | +$529K |
|
298
Yum! Brands
YUM
$41B
| $17.8M | 0.09% |
278,751
-83,963
| -23% | -$5.47M |
|
299
Skyworks Solutions
SWKS
$9.06B
| $17.8M | 0.08% |
181,361
-14,904
| -8% | -$1.36M |
|
|
HZNP
300
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $17.6M | 0.08% |
1,193,420
+52,882
| +5% | +$856K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.